(“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions ...

The program, funded through grants from the National Oceanic Atmospheric Administration, is part of a larger goal to partner with universities across the state to gain a greater understanding of the ...

Cheatgrass was brought into the US in the 1880s and made its way into every county in Idaho by the 1980s. Once it dries up in ...

Money might not buy love or happiness, but purpose can. Purpose sparks joy, builds connections, and leads to a life of ...

The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...

Increased use of ventilation and air cleaners, designed to mitigate the spread of viral infections in hospitals, is likely to have unpredictable effects and may cause viral particles to move around ...

A study links COVID-19 infection to higher ME/CFS rates, supporting Ampligen's potential as a treatment for affected individuals. AIM ImmunoTech Inc. has commented on a recently published study in ...

(“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions ...

A new report says advanced artificial intelligence systems have the potential to create extreme new risks, such as fueling ...

Jan. 23, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and ...

In the pursuit of weight loss, individuals often find themselves overwhelmed by countless products and methods that promise ...